Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Related GILD
2 Columbia Growth Funds Notch Impressive Three-Month Performance
This Top Growth Fund Leans Heavily On Large-Cap Tech
Yellen Swats Down Biotech, Social Media Stocks (Fox Business)
Related CELG
US Stock Futures Flat; All Eyes On FOMC Decision
Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks
Yellen Swats Down Biotech, Social Media Stocks (Fox Business)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas

 

Related Articles (ALXN + BIIB)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters